1. Increasing demand for personalized medicine and healthcare solutions
2. Advancements in genomics and bioinformatics technologies
3. Rising adoption of computational biology in drug discovery and development
4. Growing investments in research and development of computational biology solutions
Industry
Report Coverage | Details |
---|---|
Segments Covered | End-User, Application |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Accelrys, Chemical Computing Group, Entelos, In-silico Biotechnology AG, Nimbus Discovery LLC, Rhenovia Pharma SAS, Certara, Compugen, Generate AG, Leadscope |
1. Lack of skilled professionals in computational biology
2. Data security and privacy concerns
3. High cost of computational biology software and technologies